Search clinical trials for: AntiCov-220 (2)

Total 19248 results

MedImmune LLC
GlaxoSmithKline

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Cancer

United States
Seoul National University Hospital
HK inno.N Corporation; Kureha Corporation

Completed

Kremezin Study Against Renal Disease Progression in Korea (K-STAR)

Chronic Kidney Disease

Korea, Republic of
Devalingam Mahalingam
GenSpera, Inc.

No longer available

Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
GenSpera, Inc.

Withdrawn

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer.

United States
Chang Gung Memorial Hospital

Completed

Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.

Chronic Kidney Disease | AST-120

Taiwan
LivaNova

Completed

Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker (DREAM)

Bradycardia

France, Spain
Vanderbilt University Medical Center
Vanderbilt Institute for Clinical and Translational Research (Learning Healthcare...

Completed

The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal

Penicillin Allergy

United States
Research in Real-Life Ltd
Napp Pharmaceuticals Limited

Completed

A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down

Asthma

United Kingdom
Memorial Sloan Kettering Cancer Center
Hookipa Biotech GmbH; Naveris

Recruiting

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

HPV16+ Squamous Cell Carcinoma

United States
Ferrer Internacional S.A.

Not yet recruiting

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy
Glyscend, Inc.

Recruiting

A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity

Obesity

United States
University of Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Recruiting

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

Biomarkers | Acute Kidney Injury

United States
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation

Recruiting

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa (CoTeT)

COVID-19

South Africa
GenSpera, Inc.
Food and Drug Administration (FDA)

Completed

Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma

Glioblastoma Multiforme

United States
Bradley A. McGregor, MD
Calithera Biosciences, Inc

Completed

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Groupe Francophone des Myelodysplasies

Active, not recruiting

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia Acute Myeloid

France
Ono Pharmaceutical Co. Ltd

Completed

A Phase 1 Study of ONO-2020 in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company
Loxo Oncology, Inc.

Active, not recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

Carcinoma, Non-Small-Cell Lung | Thyroid Neoplasms

United States
Eli Lilly and Company

Active, not recruiting

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Neoplasms, Hematologic

United States, Germany, Australia, Sweden, France, Spain, Italy, Austria, Canada
Eli Lilly and Company
Loxo Oncology, Inc.

No longer available

Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor

Carcinoma, Non-Small-Cell Lung | Thyroid Neoplasms
Sakarya University

Completed

The Effect of the Education Given to Nursing Students With Web 2.0 Tools on the Level of Participation, Attitude, Interest and Motivation

Educational Problems

Turkey
ILIAS Biologics Inc.

Completed

A Study to Evaluate the Safety and Tolerability of ILB-202

Healthy

Australia
Conmed Pharmaceutical & Bio-Medical Corporation
Chang Gung Memorial Hospital; Kaohsiung Medical University; Tri-Service General... and other collaborators

Completed

AST-120 in Hemodialysis Patients With Uremic Pruritus (AST-120)

Uremic Pruritus

Taiwan
Tear Film Innovations, Inc.

Completed

Tear Film Innovations iLux Safety Study

Meibomian Gland Dysfunction | Evaporative Dry Eye

United States
DBV Technologies

Enrolling by invitation

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children (EPOPEX)

Peanut Allergy

United States
Leiden University Medical Center

Completed

The Box 2.0: Using Smart Technology for Early Diagnosis of Complications After Cardiovascular Surgery

Mobile Health | Rehabilitation After Cardiovascular Surgery

Netherlands
Radboud University Medical Center
Bayer

Completed

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Bone Metastases | Castrate Resistant Prostate Cancer

Netherlands
Medasense Biometrics Ltd

Terminated

Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure

Degenerative Diseases, Nervous System

Israel
Bürgerspital Solothurn
University Hospital, Basel, Switzerland

Completed

Comparison of Two Types of Braces in the Treatment of Rockwood Type III AC-dislocations

Acromioclavicular Joint Dislocation

Switzerland
Tear Film Innovations, Inc.

Completed

iLux Treatment for Meibomian Gland Dysfunction (MGD)

Evaporative Dry Eye

United States
Shirley Ryan AbilityLab
U.S. Department of Education

Completed

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

Spinal Cord Injury

United States
Derming SRL

Completed

Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes

Under-eyes Dark Circles

Italy
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)

Peripheral Arterial Disease

Austria
Sienna Biopharmaceuticals

Completed

Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

Pruritus | Psoriasis Vulgaris

United States
Andrew J. Armstrong, MD
Novartis Pharmaceuticals

Terminated

BKM120 in Metastatic Castration-resistant Prostate Cancer

Prostate Cancer | Metastatic (Spread to Other Areas of the Body)

United States
University of Zurich

Completed

The Butler-Program 2.0: An Internet Platform for Elderly

Quality of Life

Switzerland
Glycadia

Completed

Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

Diabetic Nephropathy
Singapore National Eye Centre

Completed

Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands

Dry Eyes

Singapore
Akron Molecules AG

Completed

A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain

Osteoarthritis

Austria
Chordate Medical

Terminated

PBASE-system Acute Migraine Clinical Investigation

Acute Migraine

United Kingdom
MediciNova

Completed

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

Asthma

United States
Trinomab Biotech Co., Ltd.
TIGERMED AUSTRALIA PTY LIMITED

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults

Healthy Adult Subjects

Australia
MED-EL Elektromedizinische Geräte GesmbH

Completed

Front-End Processing 3.0 (FEP3)

Hearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral

Germany
Celgene

Completed

Radiolabeled Study of AG-221 in Healthy Male Subjects.

Healthy Volunteers
RemeGen Co., Ltd.

Recruiting

A Study of Telitacicept in Lupus Nephritis

Lupus Nephritis

China
Novartis Pharmaceuticals

Recruiting

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Non-Small Cell Lung Carcinoma

India
Northwestern University
National Institute on Drug Abuse (NIDA); Emory University; Hunter College of...

Completed

Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men (KIU!)

HIV | Chlamydia | Gonorrhea

United States
Newcastle University
Northumbria Healthcare NHS Foundation Trust

Unknown

Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates

Colorectal Cancer

United Kingdom
ACO Hud Nordic AB
The University of Sheffield Medical School

Completed

A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Dermatitis, Atopic

United Kingdom
International Partnership for Microbicides, Inc.
National Institutes of Health (NIH)

Completed

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel (DAP/LNG)

HIV Prevention

United States

Search clinical trials for: AntiCov-220 (2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations